Trial intelligence / Profile preview

Tissucol Duo for prevention of anastomotic leakage in high-risk gastrointestinal anastomoses

2007-003006-98Phase 4Active

Sponsor
Gregorio Marañón University General Hospital
Start
Jun 2007
Modality
Recombinant Proteins and Enzymes, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of tisseel in anastomotic dehiscence (AD) and enteric fistula (2 arms), sponsored by Gregorio Marañón University General Hospital. Primary endpoint: Presence or absence of anastomotic leaks during the postoperative period. Started Jun 2007; status: active.

02

Drugs

tisseel
03

Conditions

anastomotic dehiscence (AD)enteric fistula

Beyond the preview

Go deeper on 2007-003006-98.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-003006-98.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call